2315.HK
2315.HK
CNE100005D27
BIOCYTOGEN-B
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Market & Enterprise Value
Market Cap
30.7B EUR
20.73B EUR
Enterprise Value
30.57B EUR
20.53B EUR
Valuation Multiples
Trailing P/E
72.84x
--
Forward P/E
45.13x
--
Price to Sales
18.07x
--
Price to Book
10.89x
8.56x
EV/Revenue
17.99x
--
EV/EBITDA
58.23x
--
Price to FCF (P/FCF)
959.73x
--
EV/FCF
955.73x
--
FCF Yield
0.1%
--
ende